Related Experiment Video
Updated: Jun 16, 2026
11:56
Generation of Mice Derived from Induced Pluripotent Stem Cells
Published on: November 29, 2012
[Generation of factor VIII gene knockout mouse by tetraploid embryo complementation technology].
Ying Kuang1, Jinjin Wang, Xibin Lu
1Shanghai Research Center for Biomodel Organism, Shanghai, 201210 P.R.China.
Summary
Researchers created a Factor VIII (FVIII) gene knockout mouse model for hemophilia A studies. This model exhibits FVIII deficiency, mimicking human hemophilia A, and aids in developing new treatments.
Area of Science:
- Genetics and Molecular Biology
- Hematology
Context:
- Hemophilia A is a genetic bleeding disorder caused by deficiency in coagulation Factor VIII (FVIII).
- Developing accurate animal models is crucial for understanding disease mechanisms and testing novel therapies.
Purpose:
- To establish a Factor VIII (FVIII) gene knockout mouse model for the study of hemophilia A.
- To characterize the molecular and phenotypic consequences of FVIII gene disruption in mice.
Summary:
- Exons 16-19 of the mouse FVIII gene were successfully knocked out using advanced genetic engineering techniques.
- Molecular analyses (PCR, RT-PCR, immunohistochemistry) confirmed FVIII deficiency at both transcriptional and translational levels.
- Phenotypic analysis revealed prolonged activated partial thromboplastin time (APTT) and significantly reduced FVIII activity (FVIII:C) in knockout mice, consistent with hemophilia A.
Impact:
- The established FVIII knockout mouse model accurately recapitulates the phenotype of human hemophilia A.
- This model provides a valuable platform for preclinical research and the development of innovative treatments for hemophilia A.
